At equal molar dosages of 10?nM, immunoconjugates with a single, two, and 3 ONC payloads reduced the mean viability of Daudi cells by 38%, 64%, and 84%, respectively
At equal molar dosages of 10?nM, immunoconjugates with a single, two, and 3 ONC payloads reduced the mean viability of